Background. Vitamin supplementation is used for many purposes with mainly alleged benefits. One of these is the use of various vitamins for the prevention of prostate cancer. Methods. We conducted a systematic review and meta-analysis on this topic. Pubmed, Embase and the Cochrane Database were searched; as well, we hand searched the references in key articles. Randomized controlled trials (RCTs), cohort studies and case-control studies were included. The review assessed the effect of supplemental vitamins on the risk of prostate cancer and on disease severity and death in men with prostate cancer. Results. Fourteen articles were included in the final assessment. Individually, a few of these studies showed a relationship between the ingestion of supplemental vitamins or minerals and the incidence or severity of prostate cancer, especially in smokers. However, neither the use of multivitamin supplementation nor the use of individual vitamin/mineral supplementation affected the overall occurrence of prostate cancer or the occurrence of advanced/metastatic prostate cancer or death from prostate cancer when the results of the studies were combined in a meta-analysis. We also conducted several sensitivity analyses by running meta-analysis using just the higher quality studies and just the RCTs. There were still no associations found. Conclusions. There is no convincing evidence that the use of supplemental multivitamins or any specific vitamin affects the occurrence or severity of prostate cancer. There was high heterogeneity among the studies so it is possible that unidentified subgroups may benefit or be harmed by the use of vitamins.
Introduction
In 2008, prostate cancer remained the most commonly diagnosed cancer besides non-skin epithelial malignancy in the male population. 1 Thus, defining substances that affect the risk of prostate cancer could potentially be life saving for some men. Many researchers are assessing vitamin and mineral supplementation with respect to prostate cancer risk. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] In particular, multivitamins, vitamin E, vitamin C, zinc, selenium and beta-carotene have been studied in this regard. While this area is important as supplementation is becoming more popular all around the world, the literature that has been published on this subject is inconsistent. Multivitamins have been shown to be of no benefit, 9 inconlusive 4 and potentially harmful 14 in relation to their effect on risk of prostate cancer. Similarly, vitamin E has been shown to be beneficial, 5, 15 harmful, 13, 14 and inconclusive 3, 8 in relation to risk of prostate cancer. The same inconsistencies in results are true for zinc, 6, 14, 15 selenium, 2, 14 and betacarotene. 5, 10, 14 These variations in results make the relationship between vitamins and minerals and prostate cancer difficult to interpret. In this study, we systematically reviewed the literature and performed metaanalysis in an attempt to better understand and interpret the literature. The PRISMA checklist 16 is used as a guide to the format of this article although it is not slavishly followed. As well, the PRISMA flowchart describes the systematic review process (Fig. 1) .
Our PICO formulated question for this systematic review is 'Do men who take supplemental vitamins and minerals, specifically multivitamins, vitamin E, vitamin C, zinc, selenium, and beta-carotene, have lower risk of developing prostate cancer, or if they do, have less severe disease and lower mortality, then men who do not take these vitamins and minerals as supplements to their diet'.
Methods

Eligibility criteria
Only randomized controlled trials (RCTs), cohort studies or case-control studies were eligible for inclusion in the review. Studies had to have looked at supplementation of individual vitamins or supplementation of multivitamins as the exposure, and their primary outcome had to be either occurrence of prostate cancer, advanced/metastatic prostate cancer or death due to prostate cancer. Family Practice-an international journal
Information sources
We scanned the titles of the 364 articles to remove those that were obviously related to basic science work, those that looked at dietary vitamins and not supplemental vitamins and those that looked at serum vitamin levels as the independent variable rather than vitamin supplementation. We removed commentaries, nonsystematic reviews and descriptive studies, and we removed others that were not directly related to supplemental vitamins (or minerals) and risk of prostate cancer or death from prostate cancer. This left 31 articles.
Study selection and quality assessment The abstracts of the 31 identified papers were reviewed and 14 met our study design, exposure and outcomes criteria. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] We hand searched the references in these 14 articles and did not find any additional papers that met the search or selection criteria.
The full content of these 14 papers were reviewed independently by each of the two authors using the US Preventive Services Task Force Quality Rating Criteria (http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= hsevidsyn&part=A52999). This quality rating system has specific features that are considered for each of the types of methodologies (RCTs, cohort and casecontrol) that were used in the articles. Using this system, each article is given an overall rating of good, fair or poor. After independently reviewing the 14 articles, the two authors met to discuss differences in their rating. Consensus was reached that all 14 articles were either fair or good and hence all were included in the systematic review.
There were four RCTs, eight cohort studies and two case-control studies included in the analysis. All four RCTs were blinded and placebo controlled. Concealed allocation was not specifically discussed in either of the RCTs although the process described suggests that they all used concealment. Details of the each of the studies are listed in Table 2 including dosages of the vitamins used in the RCTs. The countries in which the studies were conducted are also listed. The content of multivitamins varied from study to study but generally contained a wide range of vitamins and minerals. Figure 1 (PRISMA diagram) outlines the literature search and article selection process. Table 1 shows the main author, publication date, exposures and outcomes assessed, for each of the 14 articles.
Meta-analysis
The Cochrane Collaboration software, Revman 5, was used for the meta-analysis 17 (http://www.cc-ims.net/ revman/about-revman-5). We registered the 14 studies in Revman, entered the basic data and generated the forest plots. A Mantel-Haenzel odds ratio was calculated for each of the forest plots; a random effects model was used because of the high level of heterogeneity among the studies. This is a more conservative approach than the fixed effects model. The random A 32% decrease (95% CI, -47% to -12%) in the incidence of prostate cancer was observed among the subjects receiving alpha-tocopherol compared with those not receiving it. Mortality from prostate cancer was 41% lower (95% CI, -65% to -1%) among men receiving alphatocopherol.This study concluded that vitamin E 50 mg/day reduced prostate cancer incidence and death. Gonzalez et al. Occurrence of prostate cancer. Advanced/metastatic prostate cancer.
No effect on incidence of prostate cancer (HR, 0.82; 95% CI, 0.58 to 1.14) Decreased risk of advanced/metastatic prostate cancer (HR, 0.34; 95% CI, 0.13 to 1.09). They concluded that long-term supplemental zinc intake was associated with reduced risk of clinically relevant advanced disease. Family Practice-an international journal effects model accounts for between-study as well as within-study variation.
Results
The meta-analyses did not show any benefit of any of the individual vitamin or multivitamin supplementation included in this review. Some individual studies showed a beneficial effect for some supplements but in general, there was a wide range of results. For instance, in the studies looking at vitamin E supplementation, three studies suggested a beneficial effect, three suggested a potential harmful effect and four suggested no effect whatsoever. This wide range of effects led to a high statistical heterogeneity with I 2 results in the range of 65%-95%. However, it also suggests that publication bias is low. Also, there were interesting subgroup results in some studies: Heinonen showed a decrease in incidence and mortality from prostate cancer in smokers who used vitamin E supplementation. However, Chan's study suggested increased risk of metastases from prostate cancer in men using vitamin E. As discussed in the introduction, these kinds of discrepancies indicate the need for a meta-analysis.
Results are presented in two ways. Qualitatively each of the 14 studies and their results are presented in Table 2 . Quantitatively, meta-analysis was used to combine the results of the studies. Mantel-Haenzel odds ratios and 95% confidence intervals were determined for each study and combined into an overall effect for each exposure and outcome measured in the studies. Figure 2 shows the results of meta-analysis for the outcome: occurrence of prostate cancer. Neither the use of multivitamin supplementation nor the use of individual vitamin/mineral supplementation affected the occurrence of prostate cancer when the results of the studies were combined in a meta-analysis. Figure 3 shows the results of meta-analysis for the outcome: advanced/metastatic prostate cancer or death from prostate cancer. Neither the use of multivitamin supplementation nor the use of individual vitamin/mineral supplementation affected the occurrence of advanced/metastatic prostate cancer or death from prostate cancer when the results of the studies were combined in a meta-analysis.
We also conducted several sensitivity analyses by running meta-analysis using just the higher quality studies and just the RCTs. There were still no associations found. 
Discussion
Individually, some of the studies we included in this review did show an association between the consumption of supplemental vitamins and minerals and the occurrence of prostate cancer. However, these associations were often weak and some studies showed a positive influence while others showed a negative influence on prostate cancer. As well, two studies showed a relationship only in smokers. Overall, when all the identified eligible studies were combined in meta-analyses, there was no effect of any of the vitamins or multivitamins on the occurrence or severity of prostate cancer.
Clinical implications
While some studies suggest benefit with some vitamins, other studies show potential harm. There is no convincing evidence from this review that clinicians should recommend multivitamins, vitamin E, vitamin C, zinc, selenium or beta-carotene to their male patients in an attempt to prevent prostate cancer nor any evidence that these vitamins and minerals will help in secondary prevention in men who have a diagnosis of prostate cancer.
Limitations
The major limitation is the conduct of a meta-analysis in the presence of high heterogeneity among the studies. While we used a random effects model to try to mitigate the heterogeneity as an issue, and while our sensitivity analyses did not change the results, it is possible that an unidentified subgroup may benefit from, or be harmed by, vitamin supplementation.
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